Fig. 3From: Immune-related adverse events: a retrospective look into the future of oncology in the intensive care unitKaplan–Meier curves for overall survival of patients admitted for irAE compared to intE (p = 0.172) and TumProg patients (p < 0.001) (irAE versus others p = 0.004). irAE immune-related adverse event, TumProg complication related to tumor progression, intE intercurrent eventBack to article page